{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-235275","form_type":"8-K","ticker":"CRNX","cik":"0001658247","company_name":"Crinetics Pharmaceuticals, Inc.","filed_at":"2024-10-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.130579+00:00","generated_at":"2026-05-30T17:22:28.354000+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Crinetics prices upsized $500M public offering at $50/share; net proceeds ~$472M","bullets":["Pricing of 10,000,000 shares of common stock at $50.00/share for gross proceeds of $500.0 million.","Net proceeds estimated at approximately $472.0 million (or ~$542.9 million if 1.5M share option exercised).","Underwriters granted 30-day option to purchase up to 1,500,000 additional shares; closing expected October 10, 2024.","Proceeds to fund R&D of clinical-stage candidates, pre-commercialization activities, and general corporate purposes.","Leerink Partners and Morgan Stanley acting as joint bookrunning managers for the offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-235275","json":"https://secwatch.observer/filing/0001193125-24-235275.json","markdown":"https://secwatch.observer/filing/0001193125-24-235275.md","text":"https://secwatch.observer/filing/0001193125-24-235275.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658247/000119312524235275/0001193125-24-235275-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658247/000119312524235275/d857933d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T17:22:28.354000+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}